CHEMINFORMATICS.ORG
Today's Pharma Headlines: FDA expands GSK’s Trelegy Ellipta indication in COPD - AstraZeneca’s lung cancer combo fails in phase III trial - Shire considers Takeda's revised £46bn takeover offer - ...